42
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Steady-State Kinetics of 5-Aminosalicylic Acid and Sulfapyridine during Sulfasalazine Prophylaxis in Ulcerative Colitis

, , , , , , , , , & show all
Pages 693-700 | Received 18 Dec 1985, Accepted 15 Jan 1986, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

O. H. Nielsen, P. N. Bouchelouche, D. Berild & I. Ahnfelt-Rønne. (1993) Effect of 5-Aminosalicylic Acid and Analogous Substances on Superoxide Generation and Intracellular Free Calcium in Human Neutrophilic Granulocytes. Scandinavian Journal of Gastroenterology 28:6, pages 527-532.
Read now
S. Almer, B. Norlander, M. Ström & H. Osterwald. (1991) Steady-State Pharmacokinetics of a New 4-Gram 5-Aminosalicylic Acid Retention Enema in Patients with Ulcerative Colitis in Remission. Scandinavian Journal of Gastroenterology 26:3, pages 327-335.
Read now
M. C. M. Rijk, A. Van Schaik & J. H. M. Van Tongeren. (1988) Disposition of 5-Aminosalicylic Acid by 5-Aminosalicylic Acid-Delivering Compounds. Scandinavian Journal of Gastroenterology 23:sup148, pages 54-59.
Read now
. (1988) Introduction. Scandinavian Journal of Gastroenterology 23:sup150, pages 3-21.
Read now
M. C. M. Rijk, A. Van Schaik & J.H. M. Van Tongeren. (1988) Disposition of 5-Aminosalicylic Acid by 5-Aminosalicylic Acid-Delivering Compounds. Scandinavian Journal of Gastroenterology 23:1, pages 107-112.
Read now
S. N. Rasmussen, K. Lauritsen, U. Tage-Jensen, O. H. Nielsen, P. Bytzer, O. Jacobsen, K. Ladefoged, M. Vilien, V. Binder, J. Rask-Madsen, S. Bondesen, S. Honore Hansen & E. F. Hvidberg. (1987) 5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®. Scandinavian Journal of Gastroenterology 22:7, pages 877-883.
Read now
Lisbet Ambrosius Christensen, Steen Nøby Rasmussen, Steen Honoré Hansen, Stig Bondesen & Eigill G. Hvidberg. (1987) Salazosulfa Pyridine and Metabolites in Fetal and Maternal Body Fluids with Special Reference to 5-Aminosalicylic Acid. Acta Obstetricia et Gynecologica Scandinavica 66:5, pages 433-435.
Read now

Articles from other publishers (33)

Viviane Doggwiler, Chasper Puorger, Valeria Paredes, Michael Lanz, Katja M. Nuss, Georg Lipps & Georgios Imanidis. (2023) Efficient colonic drug delivery in domestic pigs employing a tablet formulation with dual control concept. Journal of Controlled Release 358, pages 420-438.
Crossref
Rena H Cao & Michael C Grimm. (2020) Pregnancy and medications in inflammatory bowel disease. Obstetric Medicine 14:1, pages 4-11.
Crossref
Reena Khanna & John K. Marshall. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 389 397 .
Ole Haagen Nielsen, Cynthia Maxwell & Jakob Hendel. (2013) IBD medications during pregnancy and lactation. Nature Reviews Gastroenterology & Hepatology 11:2, pages 116-127.
Crossref
Christopher J. Damman. (2013) Salicylates and the Microbiota: A New Mechanistic Understanding of an Ancient Drug's Role in Dermatological and Gastrointestinal Disease. Drug Development Research 74:6, pages 344-352.
Crossref
Ole Haagen Nielsen, Jacob Tveiten Bjerrum, Hans Herfarth & Gerhard Rogler. (2013) Recent Advances Using Immunomodulators for Inflammatory Bowel Disease. The Journal of Clinical Pharmacology 53:6, pages 575-588.
Crossref
Reena Khanna & John K. Marshall. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 453 466 .
DC Wilson, AG Thomas, NM Croft, E Newby, AK Akobeng, A Sawczenko, JME Fell, MS Murphy, RM Beattie, BK Sandhu & SG Mitton. (2010) Systematic Review of the Evidence Base for the Medical Treatment of Paediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 50:Suppl 1, pages S14-S34.
Crossref
Bhupinder K Sandhu, John ME Fell, R Mark Beattie, Sally G Mitton, David C Wilson & Huw Jenkins. (2010) Guidelines for the Management of Inflammatory Bowel Disease in Children in the United Kingdom. Journal of Pediatric Gastroenterology & Nutrition 50:Suppl 1, pages S1-S13.
Crossref
Garry G. Graham. 2005. Antirheumatic Therapy: Actions and Outcomes. Antirheumatic Therapy: Actions and Outcomes 1 24 .
W. J. Sandborn & S. B. Hanauer. (2003) The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis. Alimentary Pharmacology & Therapeutics 17:1, pages 29-42.
Crossref
S.P.L. Travis & D.P. Jewell. (1994) Salicylates for ulcerative colitis—their mode of action. Pharmacology & Therapeutics 63:2, pages 135-161.
Crossref
Lisbet A. Christensen, Jan Fallingborg, Bent A. Jacobsen, Kirsten Abildgaard, Henrik H. Rasmussen, Sten N. Rasmussen & Steen H. Hansen. (1993) Bioavailability of 5-aminosalicylic acid from slow release 5-aminosalicylic acid drug and sulfasalazine in normal children. Digestive Diseases and Sciences 38:10, pages 1831-1836.
Crossref
S. M. GREENFIELD, N. A. PUNCHARD, J. P. TEARE & R. P. H. THOMPSON. (2007) The mode of action of the aminosalicylates in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 7:4, pages 369-383.
Crossref
S. M. GREENFIELD, D. J. BOSWELL, N. A. PUNCHARD & R. P. H. THOMPSON. (2007) The effects of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid on lipid peroxidation in erythrocytes and prostaglandin production by mononuclear cells. Alimentary Pharmacology & Therapeutics 6:6, pages 671-683.
Crossref
S A Riley, D R Lloyd & V Mani. (1992) Tests of renal function in patients with quiescent colitis: effects of drug treatment.. Gut 33:10, pages 1348-1352.
Crossref
A Ireland, J D Priddle & D P Jewell. (1992) Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell.. Gut 33:10, pages 1343-1347.
Crossref
Mary L. Harris, Henry J. Schiller, Patrick M. Reilly, Mark Donowitz, Matthew B. Grisham & Gregory B. Bulkley. (1992) Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon?. Pharmacology & Therapeutics 53:3, pages 375-408.
Crossref
O. H. Nielsen & I. Ahnfelt-Rønne. (1991) Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klinische Wochenschrift 69:21-23, pages 995-1000.
Crossref
David R. Friend. (1991) Colon-specific drug delivery. Advanced Drug Delivery Reviews 7:1, pages 149-199.
Crossref
M. De Vos, H. Verdievel, R. Schoonjans, R. Beke, G.A. De Weerdt & F. Barbier. (1991) High-performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humans. Journal of Chromatography B: Biomedical Sciences and Applications 564:1, pages 296-302.
Crossref
Jill Mancini Fitzgerald & T. Donald Marsh. (2016) Mesalamine in Ulcerative Colitis. DICP 25:2, pages 140-145.
Crossref
David A. Price Evans. (1989) N-acetyltransferase. Pharmacology & Therapeutics 42:2, pages 157-234.
Crossref
U. Klotz. 1989. Clinical Research in Gastroenterology 2. Clinical Research in Gastroenterology 2 17 30 .
Chris J.J. Mulder, Guido N.J. Tytgat, Irene T. Weterman, Willem Dekker, Paul Blok, Max Schrijver & Herbert V.D. Heide. (1988) Double-Blind Comparison of Slow-Release 5-Aminosalicylateand Sulfasalazine in Remission Maintenance in Ulcerative Colitis. Gastroenterology 95:6, pages 1449-1453.
Crossref
O. H. NIELSEN, H. W. VERSPAGET & J. ELMGREEN. (2007) Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid. Alimentary Pharmacology & Therapeutics 2:3, pages 203-211.
Crossref
O. H. Nielsen & I. Ahnfelt-Rønne. (1988) 4-Aminosalicylic Acid, in Contrast to 5-Aminosalicylic Acid, has No Effect on Arachidonic Acid Metabolism in Human Neutrophils, or on the Free Radical 1,1-Diphenyl-2-picrylhydrazyl. Pharmacology & Toxicology 62:4, pages 223-226.
Crossref
S Bondesen, JB Schou, V Pedersen, Z Rafiolsadat, SH Hansen & EF Hvidberg. (2012) Absorption of 5‐aminosalicylic acid from colon and rectum.. British Journal of Clinical Pharmacology 25:2, pages 269-272.
Crossref
JAN JESPER ANDREASEN, LEIF PERCIVAL ANDERSEN & SUSANNE HARTVIG HARTZEN. (1988) In vitro susceptibility of diarrhoea producing Gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones . APMIS 96:1-6, pages 568-570.
Crossref
I. Ahnfelt-Rønne & O. Haagen Nielsen. (1987) The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents and Actions 21:1-2, pages 191-194.
Crossref
O. H. Nielsen, K. Bukhave, J. Elmgreen & I. Ahnfelt-R�nne. (1987) Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. Digestive Diseases and Sciences 32:6, pages 577-582.
Crossref
LA Christensen, O Slot, G Sanchez, J Boserup, SN Rasmussen, S Bondesen, SH Hansen & EF Hvidberg. (2012) Release of 5‐aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time.. British Journal of Clinical Pharmacology 23:3, pages 365-369.
Crossref
S. Bondesen, U. Tage-Jensen, O. Jacobsen, S. H. Hansen, S. N. Rasmussen & E. F. Hvidberg. (1986) 5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. European Journal of Clinical Pharmacology 31:1, pages 23-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.